Background: The aim of this study was to investigate the role of pulmonary surfactant-associated protein B (SP-B) expression in the pathogenesis of neonatal respiratory distress syndrome (RDS) via detecting the protein and mRNA expression of SP-B.
Methods: A total of 60 unrelated neonates who died of RDS were chosen as the RDS group and then subgrouped into ≤32 weeks group, 32∼37 weeks group and ≥37 weeks group (n=20). Sixty neonates who died of other diseases were enrolled as controls and subdivided into 3 matched groups based on the gestational age. Western blot assay and RT-PCR were employed.
Results: In the RDS group, SP-B protein expression was reduced or deficient in 8 neonates of which 6 had no SP-B protein expression. In the control group, only 1 had reduced SP-B protein expression. The reduced or deficient SP-B protein expression in 9 neonates of both groups was noted in the ≥37 weeks group. In the RDS group, the SP-B mRNA expression was significantly lower than that in the control group. In the ≤37 weeks group, SP-B mRNA expression was comparable between the RDS group and control group. In the 32∼37 weeks group, the SP-B mRNA expression in the RDS group was significantly reduced when compared with the control group. In the ≥37 weeks group, the SP-B mRNA expression in the RDS group was dramatically lower than that in the control group.
Conclusions: Alteration of SP-B expression is present at transcriptional and translational levels. Reduction of SP-B mRNA and protein expression is involved in the pathogenesis of RDS.
1. Lyra PP, Diniz EM, Abe-Sandes K, Angelo AL, Machado TM, Cardeal M. Surfactant protein B gene polymorphism in preterm babies with respiratory distress syndrome. Braz J Med Biol Res 2011; 44(1): 66-72.
2. Nkadi PO, Merritt TA, Pillers DA. An Over view of Pulmo - nary Surfactant in the Neonate: Gene tics, Metabolism, and the Role of Surfactant in Health and Disease. Mol Genet Metab 2009; 97: 95-101.
3. Bækvad-Hansen M, Nordestgaard BG, Dahl M. Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals. Eur Respir J 2011; 37: 791-9.
4. Quasney MW, Waterer GW, Dahmer MK, et al. Asso - ciation between surfactant protein B +1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med 2004; 32: 1115-19.
5. Lin Z, De Mello DE, Batanian JR, et al. Aberrant SP-B mRNA in lung tissue of patients with congenital alveolar proteinosis (CAP). Clin Genet 2000: 57: 359-69.
6. Yin XJ, Luo FP, Li AH, et al. Relationship between reduced expression of surfactant protein B and neonatal respiratory distress syndrome in twenty Han ethnic group neonates in China. Chin J Pediatr 2008: 46(1): 9-12.
7. Yin XJ, Li LH, Wang Y, et al. A study on expression of surfactant protein B in neonatal respiratory distress syndrome. Chin J Neonatol 2011; 26: 336-9.
8. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009; 12(4): 253-74.
9. Guttentag S. Posttranslational regulation of surfactant protein B expression. Semin Perinatol 2008; 32(5): 367-70.
10. Glasser SW, Senft AP, Whitsett JA, et al. Macrophage dysfunction and susceptibility to pulmonary Pseudo mo nas aeruginosa infection in surfactant protein C-deficient mice. J Immunol 2008; 181(1): 621-8.
11. Glasser SW, Witt TL, Senft AP, et al. Surfactant protein Cdeficient mice are susceptible to respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 2009; 297(1): L64-72.